Safety of anakinra, a recombinant interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis and comparison to anti-TNF-alpha agents. [electronic resource]
Producer: 20040325Description: S35-41 p. digitalISSN:- 0392-856X
- Adult
- Aged
- Antibodies, Monoclonal -- adverse effects
- Antirheumatic Agents -- adverse effects
- Arthritis, Rheumatoid -- drug therapy
- Clinical Trials as Topic
- Drug Therapy, Combination
- Etanercept
- Female
- Humans
- Immunoglobulin G -- adverse effects
- Immunologic Factors -- adverse effects
- Infliximab
- Interleukin 1 Receptor Antagonist Protein
- Male
- Middle Aged
- Receptors, Interleukin-1 -- antagonists & inhibitors
- Receptors, Tumor Necrosis Factor
- Sialoglycoproteins -- adverse effects
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.